| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
|---|
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1233.json | Partial Arthroplasty of Hip | active | | | 2025-01 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1234.json | Partial Arthroplasty of Hip | active | | | 2023-07 | us | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1235.json | Removal, Revision and Supplement Procedures of the Lower Body and Spine | active | | | 2025-02 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1236.json | Removal, Revision and Supplement Procedures of the Lower Body and Spine | active | | | 2023-07 | us | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1237.json | Removal, Revision and Supplement Procedures of the Lower Body and Spine | active | | | 2023-07 | us | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1238.json | Primary THA Procedure | active | | | 2023-07 | us | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1239.json | Foot Ulcer | active | | | 2023-07 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1240.json | Foot Ulcer | active | | | 2023-07 | us | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1241.json | Foot Ulcer | active | | | 2023-07 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1242.json | Referral for Foot Care | active | | | 2023-07 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1243.json | Therapeutic Footwear | active | | | 2023-08 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1244.json | Foot Deformity | active | | | 2023-07 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1245.json | Foot Deformity | active | | | 2023-07 | us | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1246.json | Foot Deformity | active | | | 2023-07 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1247.json | Megestrol Medications | active | | | 2024-01 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1248.json | Meperidine Medications | active | | | 2024-01 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1249.json | Potentially Harmful Antidepressants for Older Adults | active | | | 2024-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.125.11.1004.json | Fluoride Varnish Application for Children | active | | | 2024-02 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.125.11.1007.json | Dental Caries | active | | | 2025-02 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.125.11.1009.json | Dental Caries | active | | | 2017-05 | us | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.125.11.1010.json | Clinical Oral Evaluation | active | | | 2017-05 | us | |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.125.11.1011.json | Fluoride Varnish Application for Children | active | | | 2024-02 | us | |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.125.12.1002.json | Fluoride Varnish Application for Children | active | | | 2022-03 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.125.12.1003.json | Clinical Oral Evaluation | active | | | 2017-05 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.125.12.1004.json | Dental Caries | active | | | 2021-02 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1250.json | Potentially Harmful Antihistamines for Older Adults | active | | | 2025-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1251.json | Potentially Harmful Antiparkinsonian Agents for Older Adults | active | | | 2024-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1252.json | Potentially Harmful Barbiturates for Older Adults | active | | | 2024-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1253.json | Potentially Harmful Estrogens for Older Adults | active | | | 2025-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1254.json | Potentially Harmful Gastrointestinal Antispasmodics for Older Adults | active | | | 2024-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1255.json | Potentially Harmful Pain Medications for Older Adults | active | | | 2025-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1256.json | Potentially Harmful Skeletal Muscle Relaxants for Older Adults | active | | | 2025-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1257.json | Potentially Harmful Sulfonylureas for Older Adults | active | | | 2024-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1258.json | Substance Use Disorder Long Acting Medication | active | | | 2024-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1259.json | Substance Use Disorder Short Acting Medication | active | | | 2024-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1260.json | Viloxazine | active | | | 2025-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1266.json | Diabetic Retinopathy Severity Level | active | | | 2025-01 | us | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1272.json | Diabetes | active | | | 2025-01 | us | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.1273.json | Diabetes | active | | | 2025-02 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.195.11.1003.json | Counseling for Nutrition | active | | | 2017-05 | us | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.195.11.1004.json | Counseling for Nutrition | active | | | 2023-02 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.195.12.1003.json | Counseling for Nutrition | active | | | 2022-03 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1001.json | Antibiotic Medications for Pharyngitis | active | | | 2025-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1078.json | Nifedipine Medications | active | | | 2022-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1080.json | Contraceptive Medications | active | | | 2025-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1109.json | Meperidine Medications | active | | | 2024-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1129.json | Desiccated Thyroid Medications | active | | | 2021-02 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1143.json | Isotretinoin | active | | | 2022-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1167.json | Dipyridamole Medications | active | | | 2021-02 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1205.json | Leucovorin | active | | | 2023-07 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1211.json | Aspirin and Other Antiplatelets | active | | | 2024-06 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1212.json | DTaP Vaccine | active | | | 2024-11 | us | cvx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1214.json | Hepatitis A Vaccine | active | | | 2018-03 | us | cvx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1216.json | Hepatitis B Vaccine | active | | | 2025-04 | us | cvx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1220.json | Child Influenza Vaccine | active | | | 2022-02 | us | cvx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1222.json | Inactivated Polio Vaccine (IPV) | active | | | 2021-09 | us | cvx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1228.json | Pneumococcal Conjugate Vaccine | active | | | 2023-11 | us | cvx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1232.json | Rotavirus Vaccine (3 dose schedule) | active | | | 2018-03 | us | cvx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1234.json | Varicella Zoster Vaccine (VZV) | active | | | 2017-05 | us | cvx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1235.json | Measles, Mumps and Rubella (MMR) Vaccine | active | | | 2017-05 | us | cvx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1252.json | Guanfacine Medications | active | | | 2024-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1255.json | Megestrol Medications | active | | | 2021-02 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1256.json | Meprobamate Medications | active | | | 2021-02 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1266.json | Aromatase Inhibitors | active | | | 2024-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1267.json | Glucocorticoids (oral only) | active | | | 2024-02 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1481.json | Potentially Harmful Nonbenzodiazepine Hypnotics for Older Adults | active | | | 2024-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1482.json | Potentially Harmful Antiinfectives for Older Adults | active | | | 2025-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1517.json | Dementia Medications | active | | | 2025-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1530.json | Antidepressant Medication | active | | | 2024-02 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.11.1532.json | Potentially Harmful Antipsychotics for Older Adults | active | | | 2025-01 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1001.json | Antibiotic Medications for Pharyngitis | active | | | 2017-05 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1080.json | Contraceptive Medications | active | | | 2017-05 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1143.json | Isotretinoin | active | | | 2017-05 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1170.json | Varicella Zoster Vaccine (VZV) | active | | | 2017-05 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1205.json | Leucovorin | active | | | 2017-05 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1211.json | Aspirin and Other Antiplatelets | active | | | 2024-06 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1213.json | Antidepressant Medication | active | | | 2021-03 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1214.json | DTaP Vaccine | active | | | 2017-05 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1215.json | Hepatitis A Vaccine | active | | | 2017-05 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1216.json | Hepatitis B Vaccine | active | | | 2017-05 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1218.json | Child Influenza Vaccine | active | | | 2017-05 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1219.json | Inactivated Polio Vaccine (IPV) | active | | | 2017-05 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1221.json | Pneumococcal Conjugate Vaccine | active | | | 2017-05 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1223.json | Rotavirus Vaccine (3 dose schedule) | active | | | 2017-05 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1224.json | Measles, Mumps and Rubella (MMR) Vaccine | active | | | 2017-05 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1265.json | Aromatase Inhibitors | active | | | 2018-03 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1266.json | Glucocorticoids (oral only) | active | | | 2018-03 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1480.json | Potentially Harmful Nonbenzodiazepine Hypnotics for Older Adults | active | | | 2017-05 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1481.json | Potentially Harmful Antiinfectives for Older Adults | active | | | 2017-05 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1510.json | Dementia Medications | active | | | 2019-03 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1522.json | Potentially Harmful Benzodiazepines for Older Adults | active | | | 2022-02 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.196.12.1523.json | Potentially Harmful Antipsychotics for Older Adults | active | | | 2022-02 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1005.json | Bilateral Mastectomy | active | | | 2024-02 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1009.json | Primary THA Procedure | active | | | 2023-07 | us | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1015.json | Flexible Sigmoidoscopy | active | | | 2023-02 | us | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1016.json | Flexible Sigmoidoscopy | active | | | 2017-12 | us | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1017.json | Flexible Sigmoidoscopy | active | | | 2024-02 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1020.json | Fecal Occult Blood Test (FOBT) | active | | | 2017-12 | us | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1023.json | Group A Streptococcus Test | active | | | 2024-11 | us | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1024.json | HbA1c Laboratory Test | active | | | 2023-02 | us | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1026.json | Hysterectomy with No Residual Cervix | active | | | 2023-02 | us | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1027.json | Hysterectomy with No Residual Cervix | active | | | 2024-11 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1035.json | Total Colectomy | active | | | 2024-02 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1036.json | Total Colectomy | active | | | 2021-02 | us | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1055.json | XRay Study | active | | | 2022-02 | us | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1061.json | Gastric Bypass Surgery | active | | | 2020-03 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1062.json | Gastric Bypass Surgery | active | | | 2018-03 | us | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1080.json | Primary THA Procedure | active | | | 2025-01 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1084.json | History of bilateral mastectomy | active | | | 2017-12 | us | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1085.json | History of bilateral mastectomy | active | | | 2025-01 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1086.json | Status Post Left Mastectomy | active | | | 2018-03 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1087.json | Status Post Right Mastectomy | active | | | 2018-03 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1089.json | Unilateral Mastectomy, Unspecified Laterality | active | | | 2017-12 | us | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1090.json | Unilateral Mastectomy, Unspecified Laterality | active | | | 2017-12 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1091.json | Status Post Left Mastectomy | active | | | 2017-12 | us | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1092.json | Status Post Right Mastectomy | active | | | 2017-12 | us | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1096.json | Major Transplant | active | | | 2021-09 | us | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1097.json | Major Transplant | active | | | 2021-08 | us | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1132.json | Unilateral Mastectomy Left | active | | | 2021-10 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1133.json | Unilateral Mastectomy Right | active | | | 2021-10 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1134.json | Hysterectomy with No Residual Cervix | active | | | 2023-09 | us | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1135.json | Hysterectomy with No Residual Cervix | active | | | 2020-03 | us | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1140.json | Bilateral Mastectomy | active | | | 2019-03 | us | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1143.json | Total Colectomy | active | | | 2019-03 | us | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1144.json | Unilateral Mastectomy Left | active | | | 2019-03 | us | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1145.json | Unilateral Mastectomy Right | active | | | 2019-03 | us | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.11.1148.json | Palliative Intervention | active | | | 2023-01 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.12.1005.json | Bilateral Mastectomy | active | | | 2024-01 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.12.1006.json | Primary THA Procedure | active | | | 2023-08 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.12.1010.json | Flexible Sigmoidoscopy | active | | | 2022-03 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.12.1011.json | Fecal Occult Blood Test (FOBT) | active | | | 2022-03 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.12.1012.json | Group A Streptococcus Test | active | | | 2022-03 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.12.1013.json | HbA1c Laboratory Test | active | | | 2022-03 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.12.1014.json | Hysterectomy with No Residual Cervix | active | | | 2024-01 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.12.1019.json | Total Colectomy | active | | | 2024-01 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.12.1034.json | XRay Study | active | | | 2022-03 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.12.1050.json | Gastric Bypass Surgery | active | | | 2022-03 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.12.1068.json | History of bilateral mastectomy | active | | | 2017-12 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.12.1069.json | Status Post Left Mastectomy | active | | | 2017-12 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.12.1070.json | Status Post Right Mastectomy | active | | | 2017-12 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.12.1071.json | Unilateral Mastectomy, Unspecified Laterality | active | | | 2024-01 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.12.1075.json | Major Transplant | active | | | 2024-01 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.12.1133.json | Unilateral Mastectomy Left | active | | | 2022-03 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.12.1134.json | Unilateral Mastectomy Right | active | | | 2022-03 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.198.12.1135.json | Palliative Care Intervention | active | | | 2022-03 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.199.11.1064.json | Anaphylactic Reaction to DTaP Vaccine | active | | | 2022-02 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.199.11.1100.json | Malabsorption Syndromes | active | | | 2023-02 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.199.11.1102.json | Malabsorption Syndromes | active | | | 2022-02 | us | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.199.11.1105.json | Intussusception | active | | | 2017-05 | us | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.199.11.1106.json | Intussusception | active | | | 2021-02 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.199.11.1107.json | Influenza Virus LAIV Vaccine | active | | | 2021-02 | us | cvx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.199.11.1108.json | Influenza Virus LAIV Vaccine Administered | active | | | 2021-02 | us | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.199.12.1031.json | Anaphylactic Reaction to DTaP Vaccine | active | | | 2022-03 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.199.12.1050.json | Malabsorption Syndromes | active | | | 2024-01 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1003.199.12.1056.json | Intussusception | active | | | 2017-05 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1004.2446.json | Lower Extremity Visual Inspection Test | active | | | 2023-07 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1004.2447.json | Pedal Pulse Result or Finding | active | | | 2023-07 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1004.2448.json | Monofilament Test Result or Finding | active | | | 2023-07 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1004.2449.json | Monofilament Tests | active | | | 2023-07 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1004.2450.json | Lower Extremity Neurological Assessment Result or Finding | active | | | 2023-07 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1004.2451.json | Lower Extremity Neurological Tests | active | | | 2023-07 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1004.2452.json | Lower Extremity Visual Inspection Result or Finding | active | | | 2023-07 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.464.1004.2616.json | Autonomous Eye Exam Result or Finding | active | | | 2025-01 | us | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.1577.json | Pharmacologic Therapy for Hypertension | active | | | 2021-02 | us | vsac |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1036.json | Chronic Kidney Disease, Stage 5 | active | | | 2017-05 | us | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1037.json | Chronic Kidney Disease, Stage 5 | active | | | 2017-05 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1049.json | Patient Provider Interaction | active | | | 2020-03 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1058.json | Psych Visit for Family Psychotherapy | active | | | 2017-05 | us | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1063.json | Occupational Therapy Evaluation | active | | | 2017-08 | us | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1067.json | Dementia and Mental Degenerations | active | | | 2024-02 | us | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1068.json | Dementia and Mental Degenerations | active | | | 2025-02 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1069.json | Standardized Tools for Assessment of Cognition | active | | | 2017-05 | us | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1071.json | Radiation Treatment Management | active | | | 2017-08 | us | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1072.json | Radiation Treatment Management | active | | | 2017-05 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1073.json | Standardized Pain Assessment Tool | active | | | 2017-05 | us | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1078.json | Cancer | active | | | 2025-01 | us | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1079.json | Cancer | active | | | 2025-01 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1080.json | Chemotherapy Administration | active | | | 2024-01 | us | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1081.json | Chemotherapy Administration | active | | | 2025-01 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.111.json | Ophthalmological Services | active | | | 2021-02 | us | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.113.json | Prostate Cancer Treatment | active | | | 2025-02 | us | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.118.json | Initial Myocardial Infarction | active | | | 2020-03 | us | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.119.json | Initial Myocardial Infarction | active | | | 2024-02 | us | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.120.json | Coronary Artery Disease No MI | active | | | 2025-02 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1238.json | Ejection Fraction | active | | | 2025-01 | us | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1243.json | Psychoanalysis | active | | | 2017-05 | us | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1244.json | Renal Failure Due to ACE Inhibitor | active | | | 2024-02 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1251.json | Group Psychotherapy | active | | | 2017-05 | us | cpt |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1256.json | Allergy to ACE Inhibitor or ARB | active | | | 2024-02 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1257.json | Intolerance to ACE Inhibitor or ARB | active | | | 2024-02 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.133.json | Beta Blocker Therapy | active | | | 2023-02 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1333.json | Allergy to Beta Blocker Therapy | active | | | 2019-03 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1334.json | Intolerance to Beta Blocker Therapy | active | | | 2025-01 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1341.json | Heart Rate | active | | | 2024-02 | us | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1342.json | Beta Blocker Therapy for LVSD | active | | | 2022-02 | us | rx |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1344.json | Acute and Subacute Iridocyclitis | active | | | 2025-01 | us | icd |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1353.json | Limited Life Expectancy | active | | | 2025-04 | us | sct |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1363.json | Annual Wellness Visit | active | | | 2023-12 | us | cms |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1364.json | Macular Exam | active | | | 2021-02 | us | loinc |
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113883.3.526.2.1372.json | Tobacco Use Screening | active | | | 2017-05 | us | loinc |